Inify Laboratories

Less than 1K followers

INIFY

Euronext Growth Oslo

Medical Equipment & Services

Health Care

Overview

Investor consensus

Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially in prostate diagnostics. Customers primarily consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and is headquartered in Stockholm, Sweden.

Market cap

-

Turnover

-

Revenue

13.5M

EBIT %

-403.58 %

P/E

-

Dividend yield-%

-

Financial calendar

25/2

2026

Annual report '25

29/4

2026

Interim report Q1'26

20/5

2026

General meeting '26

All

Press releases

ShowingAll content types

Regulatory press release12/4/2025, 12:07 PM

INIFY: Bulletin from the extraordinary general meeting of Inify Laboratories AB

Inify Laboratories

Regulatory press release12/4/2025, 12:06 PM

Kommuniké från extra bolagsstämma i Inify Laboratories AB

Inify Laboratories

Regulatory press release12/4/2025, 12:06 PM

Bulletin from the extraordinary general meeting of Inify Laboratories AB

Inify Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release12/3/2025, 12:30 PM

Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue

Inify Laboratories

Regulatory press release12/3/2025, 12:30 PM

Inify Laboratories AB: Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue

Inify Laboratories

Regulatory press release11/28/2025, 9:57 AM

INIFY: Financial calendar

Inify Laboratories

Regulatory press release11/12/2025, 2:09 PM

Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025

Inify Laboratories

Regulatory press release11/12/2025, 2:09 PM

Inify Laboratories AB: Inify Laboratories - kallelse till extra bolagsstämma 4 december 2025

Inify Laboratories

Regulatory press release11/12/2025, 2:09 PM

Inify Laboratories AB: Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025

Inify Laboratories

Regulatory press release11/12/2025, 9:50 AM

Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Inify Laboratories

Regulatory press release11/12/2025, 9:50 AM

Inify Laboratories AB: Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Inify Laboratories

Regulatory press release11/12/2025, 9:50 AM

Inify Laboratories AB: Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Inify Laboratories

Regulatory press release10/29/2025, 10:15 AM

Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release10/29/2025, 10:15 AM

Inify Laboratories AB: Korrigering - Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026

Inify Laboratories

Regulatory press release10/29/2025, 10:15 AM

Inify Laboratories AB: Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release10/29/2025, 7:00 AM

Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release10/29/2025, 7:00 AM

Inify Laboratories AB: Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories

Regulatory press release10/29/2025, 7:00 AM

Inify Laboratories AB: Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026

Inify Laboratories

Regulatory press release8/29/2025, 9:56 AM

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release8/29/2025, 9:56 AM

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.